Followers | 139 |
Posts | 6806 |
Boards Moderated | 0 |
Alias Born | 03/20/2012 |
Thursday, June 11, 2020 8:51:17 AM
ThermoGenesis Announces Filing of Patent Applications for Device that Improves the Accuracy of Lateral Flow Immunoassays (LFIA) in the Detection of COVID-19 Antibodies
https://thermogenesis.com/thermogenesis-announces-filing-of-patent-applications-for-device-that-improves-the-accuracy-of-lateral-flow-immunoassays-lfia-in-the-detection-of-covid-19-antibodies/
RANCHO CORDOVA, Calif., June 11, 2020 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, announced today that the Company has filed patent applications for a point-of-care device which improves the speed and accuracy of lateral flow immunoassays (LFIA) to detect COVID-19 IgM and IgG antibodies from a single drop of blood. The applications for the COVID-19 LFIA reader have been filed in the United States in accordance with the recently announced USPTO COVID-19 prioritized examination Pilot Program under 37 CFR 1.102(e).
“Today’s LFIAs, in certain cases, are challenging for untrained users to properly read when results are indicated by weakly stained bands,” stated Phil Coelho, Chief Technology Officer of ThermoGenesis. “Variances among patients, if not read properly, could generate either false-negatives or false-positives. Additionally, in the large-scale screening environment, such as employer-sponsored screens of employees, record keeping by hand slows test administration and introduces the potential for recordkeeping errors.”
Mr. Coelho continued, “ThermoGenesis’ COVID-19 LFIA reader will enable the user to simply slide the test cartridge into a portable reader, providing an instant readout which can be immediately recorded into a corporate database, and/or a cloud-based web portal. This data will yield epidemiologically valuable insight into the evolution of the geographic distribution and spread of COVID-19 seropositivity in real time.”
Recent THMO News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 05:14:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2023 09:59:18 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/06/2023 05:15:20 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2023 09:30:53 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/22/2023 10:28:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2023 12:30:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/21/2023 12:30:13 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:52:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:35:12 PM
- ThermoGenesis Holdings Announces Third Quarter 2023 Financial Results and Provides Corporate Update • PR Newswire (US) • 11/13/2023 09:05:00 PM
- ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2023, and Provide a Corporate Strategic Update • PR Newswire (US) • 11/08/2023 01:31:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/03/2023 05:13:05 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/26/2023 09:03:35 PM
- ThermoGenesis to Open a New 35,500 Square Foot ReadyStart-IncuStart cGMP Facility in Greater Sacramento • PR Newswire (US) • 10/26/2023 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2023 07:27:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2023 12:33:42 AM
- ThermoGenesis Holdings to Present at the H.C. Wainwright 25th Annual Global Investment Conference • PR Newswire (US) • 09/06/2023 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2023 04:53:19 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 08/14/2023 08:27:10 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:35:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 08:15:02 PM
- ThermoGenesis Holdings Announces Second Quarter 2023 Financial Results and Provides Corporate Update • PR Newswire (US) • 08/10/2023 08:05:00 PM
- ThermoGenesis Holdings to Announce Financial Results for the Second Quarter ended June 30, 2023 and Provide a Corporate Strategic Update • PR Newswire (US) • 08/08/2023 07:26:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/03/2023 09:12:43 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM